Alzheimer Dementia Clinical Trial
— EYE-TAR(MA)Official title:
Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease and Study of the Consequences on Gaze Strategy, Behavior Disorders and Family Caregivers' Burden
NCT number | NCT04730440 |
Other study ID # | 19-02 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2019 |
Est. completion date | March 26, 2020 |
Verified date | January 2021 |
Source | Centre Hospitalier Princesse Grace |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study aims to evaluate impacts of an emotion recognition rehabilitation program, named Training of Affect Recognition, on social cognition abilities in Alzheimer's disease (AD). In addition, we hypothesis that the effect of this rehabilitation will also evolve gaze strategies, behavioral disorders, and the caregiver's burden.
Status | Completed |
Enrollment | 8 |
Est. completion date | March 26, 2020 |
Est. primary completion date | March 26, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - AD diagnosed according to l'IWG-2 (Dubois & al. 2014) criteria, - Mini-Mental State (MMS-E) =15 - Subject accompanied by a family caregiver and whose participation in a cognitive stimulation workshop was recommended in Memory Centre of the RAINIER Centre (Princesses Grace Hospital - Monaco) - Written informed consent signed by patient and family caregiver. Exclusion Criteria: - General anaesthesia within 3 months. - Ophthalmological or neurological problems preventing a video-oculography examination. - Oculomotor disorders such as "fixation disorders" or "ocular tracking disorders". - Cognitive disorders of the type: visual agnosia, visuo-spatial disorder, visuo-perceptual disorder or aphasia. - History of bipolar disorder or schizophrenia - History of alcohol abuse. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Princesse Grace | Association de Recherche Bibliographique pour les Neurosciences, Universite Cote d'Azur |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Facial emotion recognition (FER) performances | Change from Baseline and Comparison of FER performance between AD-TAR group and AD-Cognitive Stimulation group.
Evaluation criteria: Scores to Ekman Faces task (1976) and time to answer. FER was assessed using pictures from the Ekman Faces task (1976), to test the recognition of the six facial basic emotions and neutral faces. There were four pictures per emotion, for a total of 28. For each picture, participants were asked to select one of the seven labels (anger, disgust, fear, sadness, happiness, surprise and neutral), with a maximum of 8 seconds of response time per picture. |
Baseline; Week 6; 1 month post intervention | |
Primary | Affective ToM performances | Change from Baseline and Comparison of Affective ToM performance between AD-TAR group and AD-Cognitive Stimulation group.
Evaluation criteria: Scores to the " Reading the Mind in the Eyes " test (Baron-Cohen 2001). 36 black-and-white photographs of the eye area of faces. Subjets are asked to choose which word, among four options, best described what the character in the photograph was thinking or feeling. For this task, four scores were obtained: a total score (/36) and three emotional valence sub-scores: positive (/8), neutral (/16) and negative (/12). |
Baseline; Week 6; 1 month post intervention | |
Secondary | Eye gaze strategies during Facial emotion recognition (FER) | Change from Baseline and Comparison of gaze patterns between AD-TAR group and AD-Cognitive Stimulation group, during Facial emotion recognition tasks.
Evaluation criteria: Eye movements (number and duration of fixations on areas of interest) recorded with an eye-tracking device. FER was assessed using some pictures from the Ekman Faces task (1976). |
Baseline; Week 6; 1 month post intervention | |
Secondary | Behavioral disorders | Change from Baseline and Comparison between AD-TAR group and AD-Cognitive Stimulation group, Evaluation criteria: Neuropsychiatric Inventory (NPI), a scale that includes ten behavioral items (delusions, hallucinations, agitation, depression, anxiety, euphoria, apathy, disinhibition, irritability and aberrant motor behaviors) and two neurovegetative symptoms (sleep and appetite disorders). The evaluation was based on an interview with patients' primary caregivers. Both the frequency (/5) and the severity (/3) of each behavior were determined and a score was calculated by multiplying the frequency and the severity of each behavior observed during the last month. | Baseline; Week 6; 1 month post intervention | |
Secondary | The Family caregiver's burden | Change from Baseline and Comparison between AD-TAR group and AD-Cognitive Stimulation group, Evaluation criteria: The burden of the family caregiver was measured with the Zarit scale (completed by the caregiver). Composed of 22 questions on the physical, emotional and financial load felt. Total score /88. | Baseline; Week 6; 1 month post intervention | |
Secondary | Global cognitive performance | Change from Baseline and Comparison between AD-TAR group and AD-Cognitive Stimulation group, Evaluation criteria: MMSE (MINI MENTAL STATE EXAMINATION). 30-question general cognitive function assessment. The maximum score is 30. | Baseline; Week 6; 1 month post intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03255720 -
Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes
|
N/A | |
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A | |
Withdrawn |
NCT05497817 -
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia
|
N/A | |
Completed |
NCT02317523 -
Alzheimer's Caregiver Coping: Mental and Physical Health
|
N/A | |
Completed |
NCT03538522 -
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
|
Phase 2 | |
Terminated |
NCT03132272 -
Immunoadsorption for Treatment of Alzheimer's Disease
|
N/A | |
Recruiting |
NCT03275363 -
The University of Hong Kong Neurocognitive Disorder Cohort
|
N/A | |
Enrolling by invitation |
NCT03724136 -
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
|
N/A | |
Completed |
NCT02267486 -
Exploratory Study for the Validity of QuQu Scale
|
N/A | |
Active, not recruiting |
NCT03748303 -
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
|
Phase 1 | |
Completed |
NCT03611439 -
Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients
|
N/A | |
Completed |
NCT04058886 -
Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers
|
N/A | |
Recruiting |
NCT03584568 -
Reappraising Intergeneration Relationships in Dementia Caregiving
|
N/A | |
Not yet recruiting |
NCT05113732 -
Association of Cognition With Functional Mobility in People With Alzheimer's Disease
|
||
Completed |
NCT03811847 -
A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.
|
Phase 4 | |
Terminated |
NCT03044249 -
A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
|
Phase 2 | |
Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
Completed |
NCT03718494 -
Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)
|
||
Completed |
NCT03602391 -
The Senior Companion Program Plus
|
N/A | |
Completed |
NCT03548584 -
A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type
|
Phase 3 |